Homeopathy
DrugEach homeopathic medication was given as 1 g dose of homeopathic preparation in 30c potency. The dose is prepared as lactose globules on which the homeopathic preparation.
NCT Number: NCT01460043
The purpose of this study is to compare outcomes and quality-of-life issues in the treatment of menorrhagia, this randomized double blind controlled trial compared homeopathy and placebo. Clinical criteria were confirmed the diagnosis, and subjective assessment of the condition was performed during one pre-treatment and three treatment cycles. outcome measures were bleeding days, intensity. average pads used during menstrual cycle, abdominal & back pain, General health and overall satisfaction.
Looking for future studies?
Notify Me35 year–49 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each homeopathic medication was given as 1 g dose of homeopathic preparation in 30c potency. The dose is prepared as lactose globules on which the homeopathic preparation.
corresponding placebo was identical in appearance of homeopathic globule prepared in alcohol.
Time frame: change from baseline over 3 months
bleeding days, intensity of bleeding, average pads used, back and abdominal pain associated.daily assessment during menses were completed by participants at baseline before randomization and at each menses for 3 month of intervention period.
Time frame: change from baseline over 3 months
NMP Medical Research Institute
Other
Pilot Study of Homeopathy in Dysfunctional Uterine Bleeding Presenting as Menorrhagia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03670680
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bron, France
View Trial DetailsNCT04267562
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Newburgh, Indiana, United States
View Trial DetailsNCT03751800
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Many Locations, Spain
View Trial DetailsNCT03642210
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Scottsdale, Arizona, United States
View Trial Details